Abstract
Oxalobacter formigenes has been investigated for years due to its proposed ability to produce a secretagogue compound that initiates net intestinal oxalate secretion, thereby theoretically reducing circulating oxalate and risk of kidney stone formation. Strains which have been shown to exhibit this function in vivo across native tissue include the human strain, HC1, and the wild rat strain, OxWR. While previous work on these secretagogue-relevant strains has focused on profiling their metabolome and lipidome in vitro, efforts to characterize their influence on host intestinal mucosal biochemistry in vivo are yet to be reported. Much work has been done over the years with O. formigenes in relation to the secretagogue hypothesis, but it has never been clearly demonstrated that this microorganism is capable of inducing metabolic changes in native host tissue, which would be expected with the production of a transport-inducing compound. In this work, we show how the distal colonic mucosal metabolomic profile in a mouse model exhibited significant changes in the levels of a variety of metabolites as a result of oral gavage with O. formigenes HC1. Among these significant metabolites was nicotinic acid, an essential nutrient shown in past work to be produced in the gut by the native microbiome. Our finding that the in vivo biochemical state of the distal colon was altered with O. formigenes lends support to the secretagogue hypothesis and serves as a pioneering step in characterizing the biochemical interplay between O. formigenes and the mammalian host.
Highlights
The intestinal microbiome is estimated to contain thousands of different species of bacteria and each influences the health of the host in a unique manner [1]
Our findings confirm that mice gavaged with O. formigenes exhibited differential intestinal mucosal metabolic profiles than their non-gavaged counterparts
This study demonstrated that the metabolomic profile of the mouse distal colonic mucosa was altered after oral gavage with O. formigenes with our observation of significant changes in the intensities of a panel of 23 metabolite features
Summary
The intestinal microbiome is estimated to contain thousands of different species of bacteria and each influences the health of the host in a unique manner [1]. Humans lack the enzymes needed to metabolize oxalate and are dependent on their microbiome for its degradation and detoxification [7]. Perhaps the most well-studied intestinal oxalate degraders are Oxalobacter formigenes and select Lactobacillus and Bifidobacterium species [8]. When these bacteria break down oxalate in the intestine, the amount of free oxalate in the lumen that is available to be absorbed across the epithelium into the bloodstream is reduced, which theoretically lowers the risk of calcium oxalate stone formation [9].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
